Luminopia Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 18

Luminopia General Information

Description

Developer of a binocular therapeutic device designed to pioneer a new class of treatments for significant neuro-visual disorders. The company offers treatment for amblyopia, or lazy eye, using binocular vision and is developing a product to treat amblyopia which is the leading cause of vision loss among children, enabling healthcare professionals to treat significant neuro-visual disorders.

Contact Information

Website
www.luminopia.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 955 Massachusetts Avenue
  • Suite 335
  • Cambridge, MA 02139
  • United States
+1 (857)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Digital Health, Virtual Reality
Corporate Office
  • 955 Massachusetts Avenue
  • Suite 335
  • Cambridge, MA 02139
  • United States
+1 (857)

Luminopia Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Luminopia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator Completed Generating Revenue
6. Later Stage VC (Series A) 27-Jun-2023 Completed Clinical Trials - Phase 3
5. Seed Round 11-Nov-2022 Completed Clinical Trials - Phase 3
4. Debt - PPP 15-Apr-2020 Completed Clinical Trials - Phase 3
3. Seed Round 23-Mar-2020 Completed Clinical Trials - Phase 2
2. Accelerator/Incubator 02-Nov-2016 Completed Clinical Trials - Phase 1
1. Accelerator/Incubator 09-Jun-2016 Completed Clinical Trials - Phase 1
To view Luminopia’s complete valuation and funding history, request access »

Luminopia Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2
Series A-1
Seed-7
Seed-6
Seed-5
Seed-4
Seed-3
Seed-2 1,252,400 $0.001000 $0.23 $0.23 1x $0.23 2.99%
Seed-1 2,065,000 $0.001000 $2.34 $2.34 1x $2.34 4.93%
To view Luminopia’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Luminopia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a binocular therapeutic device designed to pioneer a new class of treatments for significant neuro-visual d
Therapeutic Devices
Cambridge, MA
25 As of 2024

Lausanne, Switzerland
 

Tel Aviv, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Luminopia Competitors (2)

One of Luminopia’s 2 competitors is MindMaze, a Private Equity-Backed company based in Lausanne, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MindMaze Private Equity-Backed Lausanne, Switzerland
NeuraLight Venture Capital-Backed Tel Aviv, Israel
You’re viewing 2 of 2 competitors. Get the full list »

Luminopia Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Luminopia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190366031-A1 Visual disorder treatment Active 23-May-2018
US-12076495-B2 Visual disorder treatment Active 23-May-2018
US-20200054205-A1 System and method for the treatment of amblyopia Active 02-Nov-2016
US-11826098-B2 System and method for the treatment of amblyopia Active 02-Nov-2016
US-20240108214-A1 System and method for the treatment of amblyopia Pending 02-Nov-2016 A61B3/028
To view Luminopia’s complete patent history, request access »

Luminopia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Luminopia Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Broadfin Advisors Venture Capital Minority
Good Friends Venture Capital Minority
U.S. Venture Partners Venture Capital Minority
Bantam Group Other Minority
Boston Children's Hospital Impact Investing Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Luminopia FAQs

  • When was Luminopia founded?

    Luminopia was founded in 2016.

  • Where is Luminopia headquartered?

    Luminopia is headquartered in Cambridge, MA.

  • What is the size of Luminopia?

    Luminopia has 25 total employees.

  • What industry is Luminopia in?

    Luminopia’s primary industry is Therapeutic Devices.

  • Is Luminopia a private or public company?

    Luminopia is a Private company.

  • What is Luminopia’s current revenue?

    The current revenue for Luminopia is .

  • How much funding has Luminopia raised over time?

    Luminopia has raised $32.8M.

  • Who are Luminopia’s investors?

    Broadfin Advisors, Good Friends, U.S. Venture Partners, Bantam Group, and Boston Children's Hospital are 5 of 18 investors who have invested in Luminopia.

  • Who are Luminopia’s competitors?

    MindMaze and NeuraLight are competitors of Luminopia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »